Your browser doesn't support javascript.
loading
Development of a severity scale to assess chronic lung disease after extremely preterm birth.
O'Brodovich, Hugh M; Steinhorn, Robin; Ward, Robert M; Hallman, Mikko; Schwartz, Ethan J; Vanya, Magdalena; Janssen, Ellen M; Mangili, Alexandra; Han, Linda; Sarda, Sujata P.
Afiliação
  • O'Brodovich HM; Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
  • Steinhorn R; Department of Pediatrics, University of California San Diego, San Diego, California, USA.
  • Ward RM; Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
  • Hallman M; Oulu University Hospital, University of Oulu, Oulu, Finland.
  • Schwartz EJ; Patient Centered Outcomes, ICON, Gaithersburg, Maryland, USA.
  • Vanya M; Patient Centered Outcomes, ICON, South San Francisco, California, USA.
  • Janssen EM; Patient Centered Outcomes, ICON, Gaithersburg, Maryland, USA.
  • Mangili A; Global Clinical Development, Rare Metabolic Diseases, Takeda, Zurich, Switzerland.
  • Han L; Global Clinical Development, Rare Metabolic Diseases, Takeda, Cambridge, Massachusetts, USA.
  • Sarda SP; Global Evidence and Outcomes, Takeda, Lexington, Massachusetts, USA.
Pediatr Pulmonol ; 56(6): 1583-1592, 2021 06.
Article em En | MEDLINE | ID: mdl-33729710
ABSTRACT

OBJECTIVE:

Chronic lung disease of prematurity (CLDP) is a frequent complication of prematurity. We aimed to identify what clinicians believe are the most important factors determining the severity of CLDP in extremely preterm infants (<28 weeks gestational age) after discharge from the neonatal intensive care unit (NICU) through 12 months corrected age (CA), and to evaluate how these factors should be weighted for scoring, to develop a CLDP severity scale. STUDY

DESIGN:

Clinicians completed a three-round online survey utilizing Delphi methodology. Clinicians rated the importance of various factors used to evaluate the severity of CLDP, from 0 (not at all important) to 10 (very important) for the period between discharge home from the NICU and 12 months CA. Fourteen factors were considered in Round 1; 13 in Rounds 2 and 3. The relative importance of factors was explored via a set of 16 single-profile tasks (i.e., hypothetical patient profiles with varying CLDP severity levels).

RESULTS:

Overall, 91 clinicians from 11 countries who were experienced in treating prematurity-related lung diseases completed Round 1; 88 completed Rounds 2 and 3. Based on Round 3, the most important factors in determining CLDP severity were mechanical ventilation (mean absolute importance rating, 8.89), supplemental oxygen ≥2 L/min (8.49), rehospitalizations (7.65), and supplemental oxygen <2 L/min (7.56). Single-profile tasks showed that supplemental oxygen had the greatest impact on profile classification.

CONCLUSION:

The most important factors for clinicians assigning CLDP severity during infancy were mechanical ventilation, supplemental oxygen ≥2 L/min, and respiratory-related rehospitalizations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Displasia Broncopulmonar / Nascimento Prematuro Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Displasia Broncopulmonar / Nascimento Prematuro Idioma: En Ano de publicação: 2021 Tipo de documento: Article